Emmessar Biotech and Nutrition Ltd Q1 FY23 PAT climbs to Rs. 19.53 lakhs

EMMESSAR BIOTECH & NUTRITION LTD. has reported Standalone financial results for the period ended June 30, 2022.

Financial Results (Q1 FY2023) - QoQ Comparison

The company has reported total income of Rs. 0.6487 crores during the period ended June 30, 2022 as compared to Rs. 0.8524 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs. 0.1953 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. 0.0347 crores for the period ended March 31, 2022.

The company has reported EPS of Rs. 0.39 for the period ended June 30, 2022 as compared to Rs. 0.06 for the period ended March 31, 2022.

Financials	Q1 FY2023	Q4 FY2022	% Change
Total Income	₹ 0.6487 crs	₹0.8524 crs	-23.90%
Net Profit	₹0.1953 crs	₹0.0347 crs	462.82%
EPS	₹0.39	₹0.06	550.00%

Financial Results (Q1 FY2023) - YoY Comparison

The company has reported total income of Rs. 0.6487 crores during the period ended June 30, 2022 as compared to Rs.0.4013 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs.0.1953 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.0.0880 crores for the period ended June 30, 2021.

The company has reported EPS of Rs.0.39 for the period ended June 30, 2022 as compared to Rs.0.18 for the period ended June 30, 2021.

Financials	Q1 FY2023	Q1 FY2022	% Change
Total Income	₹ 0.6487 crs	₹0.4013 crs	61.65%
Net Profit	₹0.1953 crs	₹0.0880 crs	121.93%
EPS	₹0.39	₹0.18	116.67%

Shares of EMMESSAR BIOTECH & NUTRITION LTD. was last trading in BSE at Rs. 23.60 as compared to the previous close of Rs. 22.15. The total number of shares traded during the day was 4466 in over 48 trades.

The stock hit an intraday high of Rs. 23.80 and intraday low of 21.00. The net turnover during the day was Rs. 102994.00.

Source : Equity Bulls

Keywords

EmmessarBiotechandNutrition Q1FY23 ResultUpdate